Sanofi To Cut Drug Prices In South East Asia In Experiment Aimed At Creating A Sustainable Model Of Access
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Sanofi-Aventis hopes to widen the availability of its medicines in less developed nations by slashing the price of some drugs in Southeast Asia, in a move that could be modeled after a similar program launched by GlaxoSmithKline one year ago